# Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

> **NCT07040982** · PHASE1 · NOT_YET_RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

## Interventions

- **DRUG:** Asciminib
- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Bone Marrow Aspiration
- **PROCEDURE:** Bone Marrow Biopsy
- **PROCEDURE:** Echocardiography Test
- **OTHER:** Survey Administration

## Key facts

- **NCT ID:** NCT07040982
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2028-06-13
- **Final completion:** 2028-06-13
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07040982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07040982, "Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07040982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*